Bank of America has reaffirmed Argenx (NASDAQ:ARGX) and Vertex Pharmaceuticals (NASDAQ:VRTX) as its top large-cap biotech picks for 2026, with price targets of $1 ...
Stocktwits on MSN
This small-cap biotech stock just hit a near 22-month high – but this analyst still expects another 56% rally
Zentalis selected the 400 mg dose of its drug to treat ovarian cancer after it showed a higher response rate than the 300 mg dose. ・The company expects to complete enrollment and report topline ...
Boone Capital Management sold 945,042 shares of Cogent Biosciences in the fourth quarter. As a result, the quarter-end position value decreased by $13.57 million. The position had previously accounted ...
Immutep shares rocket after a fresh FDA win The post Why this ASX biotech stock just rocketed 89% today appeared first on The ...
On February 17, 2026, Boone Capital Management sold out its entire Cogent Biosciences (NASDAQ:COGT) stake, liquidating 945,042 shares previously worth $13.57 million. According to an SEC filing dated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results